Anna Clara Machado Colucci

Anna Clara Machado Colucci

Auto-generated profile, based on publicly available information

Anna Clara Machado Colucci

Laboratory of Memory Dysfunctions, Department of Physiology, Institute for Basic Health Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2022 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
JZJanaína Zang
Janaína Zang
ACAnna Clara Machado Colucci
Anna Clara Machado Colucci
ITIsadora Tassinari
Isadora Tassinari
RNRicardo Ribeiro Nunes
Ricardo Ribeiro Nunes
MAMirella Kielek Galvan Andrade
Mirella Kielek Galvan Andrade
LFLuciano Stürmer de Fraga
Luciano Stürmer de Fraga

28 August 2026 in Neurotoxicity Research
Verified
Journal Article
Open access
PDF file
LKLayza Kowalski
Layza Kowalski
ACAnna C. M. Colucci
Anna C. M. Colucci
JSJuliana B. dos Santos
Juliana B. dos Santos
BVBeatriz W. Vuaden
Beatriz W. Vuaden
AHAlice Herlinger
Alice Herlinger
NSNadja Schröder
Nadja Schröder
Iron is an essential micronutrient for brain development, participating in mitochondrial respiration, myelination, and neurotransmitter synthesis. However, previous studies have demonstrated that excessive iron during early postnatal life induces oxidative reactions, leading to mitochondrial dysfunction and synaptic failure. These alterations compromise energy metabolism and neuronal integrity, contributing to long-lasting cognitive dysfunction and increased brain vulnerability later in life. This study evaluated the effects of cannabidiol (CBD) and cannabigerol (CBG) on behavioral, neuroinflammatory, and blood-brain barrier (BBB) outcomes in rats exposed to early-life iron overload. Male Wistar rats received iron carbonyl (30 mg/kg, intragastrically) from postnatal day 12 to 14. At three months of age, they were treated intraperitoneally with CBD, CBG (both at 10 mg/kg), or vehicle for 21 days. Cognitive performance was assessed in the open field and object recognition tasks. We examined hippocampal levels of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), as proinflammatory markers, and occludin, a protein known to regulate BBB permeability. Iron-exposed animals showed impaired recognition memory, with elevated TNF-α and IL-1β, while CBD reversed memory deficits and reduced IL-1β in iron-treated animals, without affecting TNF-α. CBG restored memory, decreased IL-1β in both iron-treated and controls, and increased TNF-α in controls. Also, iron overload reduced occludin expression in vehicle-treated rats which was reversed by both CBD and CBG. These findings highlight inflammation and BBB disruption as mediators of iron-induced cognitive dysfunction and show that both phytocannabinoids act through distinct but complementary mechanisms, supporting their therapeutic potential in neuroinflammation linked to iron overload.

20 July 2026 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
FCFernanda Borsatto Caruso
Fernanda Borsatto Caruso
MSMaria Paula Arakaki Severo
Maria Paula Arakaki Severo
ACAnna Clara Machado Colucci
Anna Clara Machado Colucci
BVBeatriz Cristina Weidle Vuaden
Beatriz Cristina Weidle Vuaden
LKLayza Kowalski
Layza Kowalski
NSNadja Schröder
Nadja Schröder